Annual Report Reveals Massive Net Loss, Highly Dilutive Offering, and Critical Internal Control Weakness
BYAH is trading near its 52-week low of $1.7 (4.1% above the low) on light trading volume (0.3× avg).
Summary
Park Ha Biological Technology reported a $24.36 million net loss for FY2025, driven by large share-based compensation, alongside a highly dilutive $2.45 million public offering and a critical internal control weakness.
Key Events · Financing and Capital Events · BYAH
-
Massive Net Loss for FY2025
The company reported a net loss of $24,364,753 for the fiscal year ended October 31, 2025, a significant decline from a net income of $478,561 in FY2024. This loss was largely due to $24,070,200 in share-based compensation expenses.
-
Highly Dilutive Public Offering Completed
On January 28, 2026, the company completed a public offering of 21,875,000 units at $0.112 per unit, consisting of Class A Ordinary Shares and warrants, raising gross proceeds of $2.45 million. This offering is highly dilutive, especially given the current stock price of $1.77.
-
Critical Internal Control Weakness Identified
Management concluded that internal control over financial reporting was not effective as of October 31, 2025, citing insufficient in-house personnel with adequate knowledge of U.S. GAAP and SEC reporting rules.
-
Reverse Stock Split to Maintain Nasdaq Listing
Following a Nasdaq non-compliance notice for minimum bid price, the company implemented a 1-for-50 reverse stock split effective February 20, 2026. This action, previously announced, is aimed at regaining compliance.
Analysis · BYAH · Industrial Applications And Services
Park Ha Biological Technology Co., Ltd.'s annual report for fiscal year 2025 highlights severe financial deterioration, reporting a net loss of $24.36 million, a dramatic reversal from previous profits. This substantial loss was primarily driven by $24.07 million in share-based compensation expenses. The company also completed a highly dilutive public offering in January 2026, issuing 21,875,000 Class A Ordinary Shares and warrants at a deep discount of $0.112 per unit, raising $2.45 million. This capital raise, while providing funds, significantly increases the share count. Furthermore, management disclosed a critical material weakness in internal control over financial reporting due to insufficient U.S. GAAP and SEC reporting expertise, a major red flag for investors. The company is also navigating Nasdaq's minimum bid price requirement, having implemented a 1-for-50 reverse stock split in February 2026. Operationally, the number of franchisees declined significantly from 45 to 22, impacting franchise fee revenue and indicating business challenges.
At the time of this filing, BYAH was trading at $1.77 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $1.70 to $2,074.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.